Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: StimCell Energetics Inc.

Market Cap 7.38M 6.4M 5.9M 5.53M 10.33M 706M 10.54M 70.38M 27.25M 340M 27.69M 27.09M 1.18B P/E Ratio 2026 *
-8.72x
P/E Ratio 2027 * -17.4x
Enterprise Value 8.18M 7.1M 6.54M 6.13M 11.45M 783M 11.69M 78.02M 30.21M 377M 30.69M 30.03M 1.31B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
28.33%
Yield 2026 *
-
Yield 2027 * -
1 day-0.44%
Current month-0.46%
1 month+19.76%
3 months+3.61%
6 months-2.47%
Current year-13.18%
1 month 0.29
Extreme 0.29
0.35
Current year 0.28
Extreme 0.281
0.48
1 year 0.25
Extreme 0.25
0.48
3 years 0
Extreme 0
13.97
5 years 0
Extreme 0
13.97
10 years 0
Extreme 0
25.35
Manager TitleAgeSince
Chief Executive Officer 56 2023-12-11
Director of Finance/CFO 48 2014-11-23
Director TitleAgeSince
Chairman 78 2024-02-25
Director/Board Member 62 2020-06-07
Director/Board Member 56 2023-12-11
Date Insider Type Main position Quantity % Market Cap.
12-17Sell

Director

16,667 0.0807%
25-03-16Tax

Director

60,841,472 307.0278%
25-02-24Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%0.00%-17.31% - 7.38M
-0.76%+0.49%-16.35%-13.14% 42.96B
+3.55%+3.23%+274.74%+508.67% 31.73B
-0.89%-2.44%+12.47%-15.54% 30.22B
+2.15%-2.00%-4.28%+24.15% 28.94B
-0.66%-5.84%+7.59%+12.76% 23.87B
-0.20%+4.26%+55.79%+117.22% 13.57B
+0.06%-0.89%+6.49%+8.03% 12.96B
+3.15%+5.68% - - 13.39B
-0.14%-0.61%+107.82%+77.82% 12.2B
Average +0.61%-1.79%+47.44%+90.00% 20.98B
Weighted average by Cap. +0.68%-2.39%+53.98%+95.46%

Financials

2026 *2027 *
Net sales - -
Net income -792M -688M -634M -594M -1.11B -75.87B -1.13B -7.56B -2.93B -36.57B -2.97B -2.91B -127B -510M -443M -408M -382M -714M -48.83B -729M -4.87B -1.88B -23.54B -1.91B -1.87B -81.85B
Net Debt 800K 694K 640K 600K 1.12M 76.6M 1.14M 7.63M 2.96M 36.92M 3M 2.94M 128M 800K 694K 640K 600K 1.12M 76.6M 1.14M 7.63M 2.96M 36.92M 3M 2.94M 128M
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
26-06-12 0.3473 $ -0.44% 234
26-06-10 - $ - 102

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!